MA
ABBV icon

MJP Associates’s AbbVie ABBV Stock Holding History

MJP Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
8,151
+159
+2% +$34.2K 0.22% 52
2026
Q1 		$1.74M Buy
7,992
+171
+2% +$37.9K 0.21% 54
2025
Q4 		$1.79M Buy
7,821
+134
+2% +$30.5K 0.22% 51
2025
Q3 		$1.78M Buy
7,687
+636
+9% +$130K 0.23% 45
2025
Q2 		$1.31M Buy
7,051
+245
+4% +$45.5K 0.19% 51
2025
Q1 		$1.43M Buy
6,806
+619
+10% +$120K 0.26% 43
2024
Q4 		$1.1M Buy
6,187
+482
+8% +$88.6K 0.2% 54
2024
Q3 		$1.13M Buy
5,705
+942
+20% +$176K 0.21% 57
2024
Q2 		$817K Sell
4,763
-136
-3% -$22.5K 0.17% 67
2024
Q1 		$892K Buy
4,899
+736
+18% +$127K 0.19% 62
2023
Q4 		$645K Sell
4,163
-694
-14% -$101K 0.17% 65
2023
Q3 		$724K Sell
4,857
-149
-3% -$21.9K 0.21% 47
2023
Q2 		$674K Sell
5,006
-3,252
-39% -$477K 0.22% 51
2023
Q1 		$1.32M Buy
8,258
+364
+5% +$55.6K 0.4% 29
2022
Q4 		$1.28M Buy
7,894
+506
+7% +$77.6K 0.37% 35
2022
Q3 		$992K Sell
7,388
-236
-3% -$33.9K 0.3% 36
2022
Q2 		$1.17M Buy
7,624
+102
+1% +$15.6K 0.33% 32
2022
Q1 		$1.22M Buy
7,522
+1,060
+16% +$154K 0.31% 38
2021
Q4 		$875K Buy
6,462
+757
+13% +$89.4K 0.26% 53
2021
Q3 		$615K Buy
5,705
+301
+6% +$34.4K 0.21% 60
2021
Q2 		$609K Buy
5,404
+409
+8% +$46.1K 0.2% 58
2021
Q1 		$541K Buy
4,995
+234
+5% +$25K 0.22% 57
2020
Q4 		$510K Buy
+4,761
New +$458K 0.21% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MJP Associates's ABBV Position: Q2 2026 in Review

MJP Associates increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $34.2K and bringing the position to 8,151 shares worth $2.05M. The position accounts for 0.22% of the portfolio, ranked #52.

MJP Associates first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MJP Associates held 8,151 shares of AbbVie worth $2.05M as of Q2 2026.
  • MJP Associates bought 159 AbbVie shares in Q2 2026, an estimated $34.2K.
  • AbbVie made up 0.22% of MJP Associates's portfolio in Q2 2026, its #52 holding.
  • MJP Associates first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.